Oscar Health, Inc. (OSCR)
| Market Cap | 3.66B |
| Revenue (ttm) | 10.08B |
| Net Income (ttm) | 123.34M |
| Shares Out | 254.36M |
| EPS (ttm) | 0.46 |
| PE Ratio | 31.13 |
| Forward PE | 31.50 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 56,735,003 |
| Open | 14.99 |
| Previous Close | 15.53 |
| Day's Range | 14.13 - 15.08 |
| 52-Week Range | 11.20 - 23.79 |
| Beta | 1.90 |
| Analysts | Sell |
| Price Target | 15.58 (+8.35%) |
| Earnings Date | Aug 6, 2025 |
About OSCR
Oscar Health, Inc. operates as a healthcare technology company in the United States. The company offers health plans to individuals, families, employees, and small group markets. It also provides +Oscar platform that power others throughout the healthcare system; Campaign Builder platform, an engagement and recommendation platform for providers and payors; and reinsurance products. The company was formerly known as Mulberry Health Inc. and changed its name to Oscar Health, Inc. in January 2021. Oscar Health, Inc. was incorporated in 2012 and is... [Read more]
Financial Performance
Financial StatementsAnalyst Summary
According to 6 analysts, the average rating for OSCR stock is "Sell." The 12-month stock price target is $15.58, which is an increase of 8.35% from the latest price.
News
Why I'm Buying Oscar's Panic Dip
Centene's $1.8B ACA risk shock triggered a ~15-20% drop in Oscar's stock but didn't alter Q1 fundamentals. Oscar posted 42% revenue growth, expanding to 2 million members with a record-low 15.8% SG&A ...
Oscar Health: Should You Buy OSCR Stock At $17?
On July 2nd, the health insurance sector underwent a notable decline following Centene (NYSE:CNC)'s retraction of its financial outlook, citing rising costs. Refer to – Centene: Is The Recent Decline ...
Oscar Health: A Misunderstood Platform
Oscar generated $328.8 million in Q1 adjusted EBITDA with a 9.8% operating margin, up 110 bps year-over-year. SG&A ratio fell to 15.8%, driven by 40% fixed-cost leverage and 15% tech-driven efficienci...
Oscar Health: Building The Operating System Of American Healthcare
Oscar Health's tech-driven flywheel is shrinking costs, boosting retention, and driving rapid membership growth, validated by 42% revenue growth and record profitability in Q1 2025. Platform revenue f...
Still Cheap After Near 100% Gains? Oscar Health Stock Could Continue Higher
Oscar Health, Inc. is undervalued despite a recent rally, with strong growth and earnings potential as a tech-driven disruptor in health insurance. The company boasts accelerating revenues, improving ...
Oscar Health: I'm Bullish, But I'm Careful
Oscar Health is uniquely undervalued, combining 42% revenue growth with profitability and a low EV/Sales multiple, making it a standout in the market. The company's $2.23B cash position versus its $4....
Oscar Health Could Be The Next Growth Monster With Tremendous Upside
Oscar Health is leveraging technology and AI to disrupt the health insurance industry, driving strong membership growth and improving operational efficiency. Financials are rapidly improving: premium ...
Oscar Health: Steep Budget Cuts In 2026 Healthcare Estimates Spell Uncertainty
I rate Oscar Health as a Hold, due to proposed steep budget cuts in the 2026 budget, impacting Medicaid and Medicare Advantage coverage. Oscar Health's impressive financials and revenue growth are ove...
Oscar Health: The Healthcare Disruptor Just Hit Its Stride
Oscar Health, Inc. delivered strong Q1 results with 42% revenue growth, improved cost control, and expanding membership, signaling sustainable profitability and margin expansion. The company stands to...
How AI helped Oscar Health cut costs and grow
Oscar Health (OSCR) stock has been rising since the company reported first quarter earnings results that beat estimates on both the top and bottom lines. Oscar Health also reaffirmed its full-year gui...
Oscar Health, Inc. (OSCR) Q1 2025 Earnings Call Transcript
Oscar Health, Inc. (NYSE:OSCR) Q1 2025 Earnings Conference Call May 7, 2025 8:00 AM ET Company Participants Chris Potochar - Vice President of Treasury and Investor Relations Mark Bertolini - Chief E...
Oscar Health Announces Strong Financial Results for First Quarter 2025 And Reaffirms 2025 Guidance
NEW YORK--(BUSINESS WIRE)--Oscar Health, Inc. (“Oscar” or the “Company”) (NYSE: OSCR), a leading healthcare technology company, announced today its financial results for the first quarter ended March ...
Oscar Health, Inc. 2025 First Quarter Earnings Conference Call
NEW YORK--(BUSINESS WIRE)--Oscar Health, Inc. (“Oscar” or the “Company”) (NYSE: OSCR), a leading healthcare technology company, will release its first quarter 2025 financial results before the market ...
Here's how Oscar Health CEO Mark Bertolini wants to fix the health insurance system
Mark Bertolini, Oscar Health CEO and former Aetna chairman and CEO, discusses potential solutions to some of the problems in the health insurance industry and why he believes the individual insurance ...
Oscar Health CEO on fixing the health insurance system: Individual insurance market is the solution
Mark Bertolini, Oscar Health CEO and former Aetna chairman and CEO, joins 'Squawk Box' to discuss potential solutions to some of the problems in the health insurance industry, why he believes the indi...
Oscar Health: The Most Undervalued Small Cap But With One Big Risk
I am bullish on Oscar Health (OSCR) due to its efficient D2C model, AI integration, and improving EBITDA margins despite high revenue growth. OSCR's opportunity in the ICHRA market is significant, wit...
Ataraxis AI to Transform Precision Medicine in Cancer Care with $20.4 Million Series A
NEW YORK--(BUSINESS WIRE)--Ataraxis AI, the leading AI precision medicine company, today announced its $20.4 million Series A financing led by AIX Ventures with participation from Floating Point, Thie...
Oscar Health, Inc. Investigated for Securities Fraud Violations - Contact the DJS Law Group to Discuss Your Rights - OSCR
LOS ANGELES , Feb. 13, 2025 /PRNewswire/ -- The DJS Law Group announces that it is investigating claims on behalf of investors of Oscar Health, Inc. ("Oscar Health" or "the Company") (NYSE: OSCR) for ...
Oscar Health, Inc. (OSCR) Q4 2024 Earnings Call Transcript
Oscar Health, Inc. (NYSE:OSCR) Q4 2024 Earnings Conference Call February 4, 2025 5:00 PM ET Company Participants Chris Potochar – Vice President of Treasury and Investor Relations Mark Bertolini – Ch...
Oscar Health Reports First Profitable Year as Digital Mix Drives Engagement
The U.S. healthcare sector has undergone a rapid digital transformation in recent years, driven by a combination of regulatory shifts, consumer demand and technological advancements. The pandemic acce...
Oscar Health Turns First Annual Profit As Obamacare Enrollment Soars
Oscar Health Tuesday reported a $25 million profit for the full year 2024 as the provider of individual and small group health insurance achieved record enrollment and revenue growth.
Oscar Health Announces Fourth Quarter and Full Year 2024 Results; Introduces Full Year 2025 Outlook
NEW YORK--(BUSINESS WIRE)--Oscar Health, Inc. (“Oscar” or the “Company”) (NYSE: OSCR), a leading healthcare technology company, today announced its financial results for the fourth quarter and full ye...
Oscar Health: Trump Uncertainty Creates Buying Opportunity
Oscar Health's targets of a 20% revenue CAGR through 2027 and 5% operating margin imply operating income around $700m in 3 years. Despite not being profitable yet, Oscar Health is projected to achieve...
Focus On Costs, Regulatory Outlook For Health Insurers In Q4'24 Earnings Season
Most publicly traded US health insurers are forecast to report sequential revenue and earnings declines for the fourth quarter of 2024, according to S&P Global Market Intelligence analysis of sell-sid...
Oscar Health, Inc. 2024 Fourth Quarter and Full Year Earnings Conference Call
NEW YORK--(BUSINESS WIRE)--Oscar Health, Inc. (“Oscar” or the “Company”) (NYSE: OSCR), a leading healthcare technology company, will release its fourth quarter and full year 2024 financial results aft...